Integra LifeSciences Holdings (IART) stock price

Integra LifeSciences Holdings (IART) is a Healthcare · Medical Devices company listed on NASDAQ. Price $15.22 (+0.79%), Market cap $1.16B, 52-week low–high $8.90 ~ $16.12.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Integra LifeSciences Holdings are updated in real time on BlackAll Trade.

Integra LifeSciences Holdings financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Integra LifeSciences Holdings (IART) stock price?

Integra LifeSciences Holdings trades at $15.22 (+0.79%). Real-time quotes and charts are available on BlackAll Trade.

What is the Integra LifeSciences Holdings (IART) market cap?

Integra LifeSciences Holdings has a market cap of about $1.16B.

What does Integra LifeSciences Holdings (IART) do?

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolar